WuXi Biologics (Cayman) Inc. (WXXWY)
USD 4.3
(-1.15%)
USD 4.3
(-1.15%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 56.57 Billion CNY | 14.15% |
| 2022 | 49.56 Billion CNY | 12.56% |
| 2021 | 44.03 Billion CNY | 52.03% |
| 2020 | 28.96 Billion CNY | 64.54% |
| 2019 | 17.6 Billion CNY | 87.39% |
| 2018 | 9.39 Billion CNY | 93.71% |
| 2017 | 4.84 Billion CNY | 144.28% |
| 2016 | 1.98 Billion CNY | 46.31% |
| 2015 | 1.35 Billion CNY | 113.1% |
| 2014 | 636.67 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 56.1 Billion CNY | 0.0% |
| 2023 Q4 | 56.57 Billion CNY | 0.0% |
| 2023 FY | 56.57 Billion CNY | 14.15% |
| 2023 Q2 | 52.14 Billion CNY | 0.0% |
| 2022 Q2 | 47.47 Billion CNY | 0.0% |
| 2022 Q4 | 49.56 Billion CNY | 0.0% |
| 2022 FY | 49.56 Billion CNY | 12.56% |
| 2021 FY | 44.03 Billion CNY | 52.03% |
| 2021 Q4 | 44.03 Billion CNY | 0.0% |
| 2021 Q2 | 43.58 Billion CNY | 0.0% |
| 2020 Q2 | 20.72 Billion CNY | 0.0% |
| 2020 FY | 28.96 Billion CNY | 64.54% |
| 2020 Q4 | 28.96 Billion CNY | 0.0% |
| 2019 Q4 | 17.6 Billion CNY | 0.0% |
| 2019 FY | 17.6 Billion CNY | 87.39% |
| 2019 Q2 | 10.2 Billion CNY | 0.0% |
| 2018 Q4 | 9.39 Billion CNY | 0.0% |
| 2018 Q2 | 8.57 Billion CNY | 0.0% |
| 2018 FY | 9.39 Billion CNY | 93.71% |
| 2017 Q2 | 5.63 Billion CNY | 0.0% |
| 2017 Q4 | 4.84 Billion CNY | 0.0% |
| 2017 FY | 4.84 Billion CNY | 144.28% |
| 2016 Q4 | 1.98 Billion CNY | 0.0% |
| 2016 FY | 1.98 Billion CNY | 46.31% |
| 2015 Q2 | 339.17 Million CNY | 0.0% |
| 2015 Q1 | 339.17 Million CNY | 113.1% |
| 2015 Q4 | 339.17 Million CNY | 0.0% |
| 2015 FY | 1.35 Billion CNY | 113.1% |
| 2015 Q3 | 339.17 Million CNY | 0.0% |
| 2014 Q3 | 159.16 Million CNY | 0.0% |
| 2014 Q4 | 159.16 Million CNY | 0.0% |
| 2014 FY | 636.67 Million CNY | 0.0% |
| 2014 Q1 | 159.16 Million CNY | 0.0% |
| 2014 Q2 | 159.16 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | -145537.31% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -783523.144% |
| SQZ Biotechnologies Company | 107.18 Million USD | -52682.265% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -535959.56% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | -43349.352% |
| Mesoblast Limited | 667.9 Million USD | -8370.681% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -78180962.668% |
| Genus plc | 1.02 Billion USD | -5398.661% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -4164923.819% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -11336834.789% |
| Marizyme, Inc. | 22.01 Million USD | -256886.297% |
| ContraFect Corporation | 20.67 Million USD | -273490.241% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -9023141.786% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -14492895.292% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -14803440.244% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -3950630.57% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -1364478.529% |
| MultiCell Technologies, Inc. | 126.22 USD | -44823107173.015% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -6020586.206% |
| RVL Pharmaceuticals plc | 128.51 Million USD | -43924.376% |
| EV Biologics, Inc. | 431.71 Thousand USD | -13104808.805% |
| Q BioMed Inc. | 3.51 Million USD | -1609214.533% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -160722.44% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -7341256.839% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -21653442.409% |
| Biomind Labs Inc. | 73.81 Thousand USD | -76641043.879% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 462.85 Million USD | -12123.234% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -188391.809% |
| Skye Bioscience, Inc. | 11.94 Million USD | -473717.241% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -1707582.496% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -2059944.605% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -2889086.182% |
| IMV Inc. | 31.33 Million USD | -180458.213% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -8229264.089% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -2173217.952% |
| GB Sciences, Inc. | 103.44 Thousand USD | -54693086.52% |
| Alpha Cognition Inc. | 2.45 Million USD | -2307069.813% |
| HST Global, Inc. | 1526.00 USD | -3707452455.701% |
| CSL Limited | 38.02 Billion USD | -48.797% |
| Halberd Corporation | 10.13 Thousand USD | -558441574.07% |
| Enzolytics Inc. | 361.7 Million USD | -15541.33% |
| Resverlogix Corp. | 8.11 Million USD | -697074.689% |
| Affymax, Inc. | 7.44 Million USD | -760019.925% |
| SYBLEU INC | 330.46 Thousand USD | -17119780.291% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -3012644.478% |
| argenx SE | 4.54 Billion USD | -1145.487% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -202361.086% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | -118502.419% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -248346004.21% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -632090.704% |
| AVAX Technologies, Inc. | 7.37 Million USD | -766804.188% |
| Zenith Capital Corp. | 7410.00 USD | -763504974.224% |
| Genscript Biotech Corporation | 3.38 Billion USD | -1570.683% |
| Ember Therapeutics, Inc. | 184.00 USD | -30747677073.913% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -17580593.337% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -21646234.614% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | -12576.36% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -3904790.04% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 3.02 Million USD | -1870118.764% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | -107252.282% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -6096678.421% |
| BioStem Technologies, Inc. | 14.56 Million USD | -388461.781% |
| ONE Bio Corp. | 70.08 Million USD | -80623.862% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -99092144.369% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -2449165527.706% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -5726379.326% |
| Agentix Corp. | 261.39 Thousand USD | -21643915.884% |
| LadRx Corporation | 2.3 Million USD | -2451313.287% |
| Cell Source, Inc. | 195.17 Thousand USD | -28987672.774% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -11772848.058% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -15999053.321% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -15999053.321% |
| NovAccess Global Inc. | 62.24 Thousand USD | -90887520.486% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -8844611.22% |
| Itoco Inc. | 1.4 Million USD | -4040815.467% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -59144265.807% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -53373226.415% |
| Kadimastem Ltd | 2.3 Million USD | -2455358.404% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -74096510.525% |
| CytoDyn Inc. | 11.13 Million USD | -507943.517% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -39571092.961% |
| Mobile Lads Corp. | 52.00 USD | -108799472976.923% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -316418949.217% |
| Qrons Inc. | 420.00 USD | -13470410852.381% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -14676938.221% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -10246898.116% |
| Rebus Holdings, Inc. | 5000.00 USD | -1131514420.0% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -13818338.188% |
| International Stem Cell Corporation | 5.39 Million USD | -1049542.412% |
| Bioxytran, Inc. | 137.63 Thousand USD | -41104628.345% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -377025.497% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -341149.327% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -71614743.038% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -6542889.579% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -752537.036% |
| Neutra Corp. | 2851.00 USD | -1984416806.349% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -174484.108% |
| PureTech Health plc | 693.97 Million USD | -8052.439% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -700867.688% |
| IXICO plc | 15.84 Million USD | -356982.002% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -683016.711% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -54655.648% |
| CSL Limited | 38.02 Billion USD | -48.797% |
| Cellectis S.A. | 333.99 Million USD | -16839.112% |